Prevalence of hepatopulmonary syndrome in patients with decompensated chronic liver disease and its impact on short-term survival

Arquivos de Gastroenterologia

Volumn 45, Issue 1, 2008, Pages 34-37

  Ferreira, Palmireno Pinheiro ^a,b   Camara, Edmundo José Nasri ^a   De Paula, Rogério Luis Porto ^a   Zollinger, Cláudio Celestino ^a   Cavalcanti, Andréa Ribeiro ^a   Bittencourt, Paulo Lisboa ^a,b,c  

^a Portuguese Hospital   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c NONE   (Brazil)

Author keywords

Chronic disease; Hepatopulmonary syndrome; Inpatients; Liver diseases

Indexed keywords

CONTRAST MEDIUM; MACROSALB TC 99M;

ADULT; AGED; ARTICLE; BRAZIL; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEPATOPULMONARY SYNDROME; HOSPITAL MANAGEMENT; HUMAN; LABORATORY TEST; LUNG ALVEOLUS OXYGEN TENSION; LUNG BLOOD VESSEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; VASODILATATION;

CHRONIC DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEPATOPULMONARY SYNDROME; HOSPITAL MORTALITY; HUMANS; IMAGE ENHANCEMENT; LIVER DISEASES; MALE; MIDDLE AGED; PREVALENCE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 42649144146     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032008000100007     Document Type: Article

References (22)

1. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology. 1995;109:1283-8.
2. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998;114:305-10.
3. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology. 2003;37:192-7.
4. Collisson EA, Nourmand H, Fraiman MH, Cooper CB, Bellamy PE, Farmer DG, Vierling JM, Ghobrial RM, Busuttil RW. Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome. Liver Transpl. 2002;8:925-31
5. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140-8.
6. Gaines DI, Fallon MB. Hepatopulmonary syndrome. Liver Int. 2004;24:397-401.
7. Gupta D, Vijaya DR, Gupta R, Dhiman RK, Bhargava M, Verma J, Chawla YK. Prevalence of hepatopulmonary syndrome in cirrhosis and extrahepatic portal venous obstruction. Am J Gastroenterol. 2001;96:3395-9.
8. Hiroto E, Mureo K, Yukiko I, Shinji U, Kastsuhiko A, Siro F, Tetsuya K, Michihiro H, Toshiya Y, Muneo Y, Yasuhiko A, James AMS, Koichi T. Long-term outcome of living related liver transplantation for patients with intrapulmonary shunting and strategy for complications. Transplantation. 1999;67:712-7.
9. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004;1:1461-8.
10. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000;118:615-24.
11. Lima BLG, França AVC, Pazin-Filho A, Araújo WM, Martinez JAB, Maciel BC, Simões MV, Terra-Filho J, Martinelli ALC. Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome. Mayo Clin Proc. 2004;79:42-8.
12. Mandell MS. Hepatopulmonary syndrome and portopulmonary hypertension in the model for end-stage liver disease (MELD) era. Liver Transpl. 2004;10:s54-8.
13. Martinez GP, Barbera JA, Visa BJ, Rimola A, Pare JC, Roca J, Navasa M, Rodes J, Rodriguez- Roisin R. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol. 2001;34:651-7.
14. Murray KF, Carithers RL Jr. AASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology. 2005;41:1407-32.
15. Pugh RN, Murray-Lyon M, Dawson JL, Pietroni C, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-9.
16. Rodrigez-Roisin R, Krowka MJ, Herve Ph, Fallon MB. Pulmonary-hepatic vascular Disorders (PHD). Eur Respir J. 2004;24:861-80.
17. Rodrigez-Roisin R, Krowka MJ, Herve Ph, Fallon MB. Highlights of the ERS task force on pulmonary-hepatic vascular disorders (PHD). J Hepatol. 2005;42:924-7.
18. Schenk P, Schoniger-Hekele M, Fuhrmann V, Nadl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125:1042-52.
19. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology. 2005;41:1122-9.
20. Taille C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F, Ichai P, Duvoux C, Belghiti J, Calmus Y, Mal H. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation. 2003;75:1482-9.
21. th ed. Baltimore: Williams and Wikins; 1990.
22. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P. Model for endstage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91-6.